EAM
AFJK

Exos Asset Management’s Aimei Health Technology Co AFJK Stock Holding History

Exos Asset Management’s Portfolio AFJK Stock Details AFJK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-300,000
Closed -$3.07M – 146
2024
Q1 		$3.07M Buy
+300,000
New +$3.05M 1.81% 25

Other funds holding AFJK

KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
MSU
Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return
CC
Centiva Capital New York $13.6B AUM 20% 1-Year Est. Return

Exos Asset Management's AFJK Position: Q2 2024 in Review

Exos Asset Management sold out of Aimei Health Technology Co (AFJK) in Q2 2024, closing a stake of 300,000 shares — an estimated $3.07M sold.

Exos Asset Management first reported a position in AFJK in Q1 2024 and held it in 1 quarter. The position peaked at $3.07M in Q1 2024. 30 funds tracked by Wall St. Rank hold AFJK as of Q2 2024.

  • Exos Asset Management reported no remaining Aimei Health Technology Co position as of Q2 2024 after selling out during the quarter.
  • Exos Asset Management sold 300,000 Aimei Health Technology Co shares in Q2 2024, an estimated $3.07M.
  • Exos Asset Management first reported a position in Aimei Health Technology Co in Q1 2024 and held it in 1 quarter.
  • Exos Asset Management's Aimei Health Technology Co position peaked at $3.07M in Q1 2024.
  • 30 funds tracked by Wall St. Rank held Aimei Health Technology Co as of Q2 2024.

Based on Exos Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.